Headlands Technologies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,167
Closed -$2.33M 865
2025
Q4
$2.33M Buy
+2,167
New +$2.07M 0.19% 115
2025
Q3
Sell
-4,250
Closed -$3.31M 998
2025
Q2
$3.31M Buy
4,250
+242
+6% +$188K 0.4% 57
2025
Q1
$3.31M Buy
4,008
+2,020
+102% +$1.68M 0.38% 63
2024
Q4
$1.53M Sell
1,988
-13,106
-87% -$10.9M 0.15% 159
2024
Q3
$13.4M Buy
15,094
+8,322
+123% +$7.48M 1.54% 6
2024
Q2
$6.13M Buy
+6,772
New +$5.42M 0.65% 27
2024
Q1
Sell
-3,710
Closed -$2.16M 1415
2023
Q4
$2.16M Buy
3,710
+1,679
+83% +$980K 0.64% 25
2023
Q3
$1.09M Buy
2,031
+1,296
+176% +$668K 0.54% 44
2023
Q2
$345K Sell
735
-183
-20% -$76.7K 0.11% 209
2023
Q1
$315K Buy
+918
New +$310K 0.21% 89

Other funds holding LLY

Headlands Technologies's LLY Position: Q1 2026 in Review

Headlands Technologies sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 2,167 shares — an estimated $2.33M sold.

Headlands Technologies first reported a position in LLY in Q1 2023 and held it in 10 quarters. The position peaked at $13.4M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Headlands Technologies reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Headlands Technologies sold 2,167 Eli Lilly shares in Q1 2026, an estimated $2.33M.
  • Headlands Technologies first reported a position in Eli Lilly in Q1 2023 and held it in 10 quarters.
  • Headlands Technologies's Eli Lilly position peaked at $13.4M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.